全文获取类型
收费全文 | 1928篇 |
免费 | 253篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 53篇 |
妇产科学 | 20篇 |
基础医学 | 280篇 |
口腔科学 | 41篇 |
临床医学 | 242篇 |
内科学 | 407篇 |
皮肤病学 | 35篇 |
神经病学 | 153篇 |
特种医学 | 26篇 |
外国民族医学 | 2篇 |
外科学 | 397篇 |
综合类 | 12篇 |
预防医学 | 165篇 |
眼科学 | 30篇 |
药学 | 146篇 |
肿瘤学 | 132篇 |
出版年
2023年 | 37篇 |
2022年 | 9篇 |
2021年 | 28篇 |
2020年 | 43篇 |
2019年 | 24篇 |
2018年 | 62篇 |
2017年 | 65篇 |
2016年 | 58篇 |
2015年 | 61篇 |
2014年 | 80篇 |
2013年 | 104篇 |
2012年 | 87篇 |
2011年 | 86篇 |
2010年 | 73篇 |
2009年 | 86篇 |
2008年 | 73篇 |
2007年 | 62篇 |
2006年 | 72篇 |
2005年 | 55篇 |
2004年 | 63篇 |
2003年 | 59篇 |
2002年 | 56篇 |
2001年 | 50篇 |
2000年 | 31篇 |
1999年 | 46篇 |
1998年 | 25篇 |
1997年 | 25篇 |
1996年 | 42篇 |
1995年 | 35篇 |
1994年 | 19篇 |
1993年 | 17篇 |
1992年 | 34篇 |
1991年 | 34篇 |
1990年 | 29篇 |
1989年 | 31篇 |
1988年 | 33篇 |
1987年 | 31篇 |
1986年 | 34篇 |
1985年 | 23篇 |
1984年 | 26篇 |
1983年 | 18篇 |
1979年 | 13篇 |
1978年 | 13篇 |
1974年 | 11篇 |
1972年 | 8篇 |
1971年 | 8篇 |
1970年 | 10篇 |
1876年 | 8篇 |
1872年 | 9篇 |
1868年 | 8篇 |
排序方式: 共有2199条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Dr. B. H.Ch. Stricker R. R. M. de Groot J. H. P. Wilson 《European journal of clinical pharmacology》1991,40(4):367-371
Summary In 1981 generalized anaphylaxis was registered on 166 occasions in Dutch general and academic hospitals. Clinical details of 120 of those patients revealed that in 107 anaphylaxis was either probable (n=90) or possible (n=17), whereas in 13 cases some other reaction than anaphylaxis had occurred. The series of confirmed cases contained 46 men and 61 women, with mean ages of 47 y and 48 y, respectively.There was a complete recovery in 102 patients and two patients died. Hypotension was present in 79 cases (74%), dyspnoea in 34 cases (32%) and a skin reaction, mainly urticaria, erythema or angioedema, was mentioned in 62 cases (58%). Most cases of anaphylaxis were drug-induced (76%), the main causes being the analgesic glafenine and contrast media. Glafenine was mentioned as the cause in 36% of all admissions for drug-induced anaphylaxis. Only 3.7% of cases had been reported to the voluntary reporting scheme of the Netherlands Centre for Monitoring of Adverse Reactions to Drugs.On the basis of reimbursement data, the risk of developing severe anaphylaxis to glafenine was estimated at 11.7–19.3-fold relative to indomethacin, and 13.4–20.2-fold relative to oral penicillins. 相似文献
5.
Ohne Zusammenfassung 相似文献
6.
Ohne Zusammenfassung 相似文献
7.
Ohne ZusammenfassungEin Charakterbild aus der Geschichte der Medicin. 相似文献
8.
C. R. Goucke MB ChB FFARACS J. P. Keaveny MB BCh BAO FFARCS B Kay DMSc MB ChB FFARCS T. E. J. Healy MSc MD FFARCS M. Ryan MB ChB FFARCS 《Anaesthesia》1990,45(4):329-331
Eighty-two outpatients who received general anaesthesia for surgical removal of maxillary or mandibular third molars were given either diclofenac 75 mg or nefopam 20 mg intramuscularly for postoperative pain control. They and the control group were also allowed oral paracetamol as required. The results showed that there was no significant pain relief from these single intramuscular injections. 相似文献
9.
J. P. Ottervanger B. H. C. Stricker T. B. van Witsen H. A. Valkenburg D. E. Grobbee 《European journal of clinical pharmacology》1994,47(4):305-309
There are several reports on cardiac adverse reactions attributed to the antimigraine drug sumatriptan in the recent literature. In order to assess the frequency and the character of adverse reactions to sumatriptan, a postmarketing cohort study was performed one year after registration of the drug in The Netherlands. With assistance of 86% of the drug dispensing general practitioners in The Netherlands, 1727 patients who had received sumatriptan were traced in July, 1992. Via their general practitioners, a questionnaire about use of sumatriptan, adverse reactions and other medication was sent to the patients in December 1992. During the study period, seven patients were lost to follow-up. Of the 1720 remaining patients, 1202 (70%) responded to the questionnaire, of whom 1187 had actually used sumatriptan. The most frequently reported suspected adverse reactions were paraesthesiae (139 patients, 95% CI 9.9%–13.5%) and dizziness (96 patients, 95% CI 6.5%–9.7%). Chest pain after use of sumatriptan was reported by 94 patients (7.9%, 95% CI 6.4%–9.4%), and according to the close temporal relationship with the intake of sumatriptan and a positive rechallenge, a causal relationship was probable in most of those patients. The frequency of chest pain attributed to sumatriptan was higher in females (9.0% vs 4.6%; relative risk 1.9, 95% CI 1.1–3.4). Age and hypertension were not associated with chest pain attributed to sumatriptan. Dyspnoea attributed to sumatriptan was reported by 26 patients (2.2%), and was associated with obstructive lung disease (relative risk 5.4 95% CI 1.7–16.9). Thus, in view of the high frequency of chest pain after use of sumatriptan and reports in the literature of cardiac disturbances, including myocardial infarction, cautious use of the drug is advised. 相似文献
10.